LuisAntonioAcabaMD

PubMed

• GROC (gemcitabine, rituximab, oxaliplatin combination) plus pegfilgrastim is less toxic and as active as DHAP and ESHAP for relapsed aggressive non-Hodgkin's lymphoma ...
  Cabanillas F, Liboy I, Rodriguez-Monge E, Pavia O, Robles N, Maldonado N, Rivera E, Torres I, Perdomo J, Acaba L> ;J. Clin. Oncol.. 2008-05-20
• Excellent response to interferon therapy in a patient with hypereosinophilic syndrome and elevated serum immunoglobulin E levels.
  Acaba, L., Mangual, A., Vélez García, E.> ;Bol Asoc Med P R. 2001 Jan 06
• Simultaneous occurrence of Hodgkin''s disease and chronic lymphocyte leukemia: a unique presentation.
  Acaba, L., Hallman, D., Rodríguez-Morales, E., Vélez, R., Vélez-García, E.> ;Bol Asoc Med P R. 2000 Jun 10
• Adult bone marrow transplantation in Puerto Rico: past, present, and future.
  Acaba, L.> ;Bol Asoc Med P R. 1998 May 13
• T-cell rich B-cell lymphoma masquerading as Hodgkin disease: excellent outcome to inadequate therapy.
  Acabá L, Santiago N, Vélez García E> ;Bol Asoc Med P R. 1996-01-01
• 13 citations
  Abnormal Liver Function in Patients Undergoing Autologous Bone Marrow Transplantation for Hematological Malignancies
  Carolyn Wasserheit, Luis Acaba, Subhash C. Gulati> ;Cancer Investigation. 1995 Jan 1
• 22 citations
  Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells
  Roberto M. Lemoli, Tadahiko Igarashi, Marianne Knizewski, Luis Acaba, Anna Richter, Ashok Jain, David Mitchell, Julia G. Levy, Subhash C. Gulati> ;Blood. 1993 Feb 1
• 1 citations
  Improving the role of hematopoietic support for high-dose cytotoxic therapy.
  Subhash C. Gulati, Luis Acaba> ;Cancer Investigation. 1993 Jan 1
• 3 citations
  Rationale for Purging in Autologous Stem Cell Transplantation
  Subhash C. Gulati, Luis Acaba> ;Journal of Hematotherapy. 1993 Jan 1
• Acute lymphoblastic leukemia: present and future.
  Gulati, S. C., Acaba, L., Maslak, P., Phillips, J., Duensing, S.> ;Leukemia. 1992 Nov
• Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow.
  Gulati, S., Acaba, L., Yahalom, J., Reich, L., Motzer, R., Crown, J., Doherty, M., Clarkson, B., Berman, E., Atzpodien, J.> ;Bone Marrow Transplant. 1992 Aug
• 102 citations
  Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow trans...
  Subhash C. Gulati, Joachim Yahalom, Luis Acaba, L Reich, Robert J. Motzer, John Crown, M Toia, Tadahiko Igarashi, R Lemoli, E Hanninen> ;Journal of Clinical Oncology. 1992 Jun 1
• 13 citations
  Purging in autologous and allogeneic bone marrow transplantation
  Subhash C. Gulati, Roberto M. Lemoli, Luis Acaba, Tadahiko Igarashi, Carolyn Wasserheit, Mustafa Fraig> ;Current Opinion in Oncology. 1992 Apr 1
• Join now to see all